Exploring the Potential of Drug Repurposing: Detection of Cystic Fibrosis Transmembrane Conductance Regulator as a Biomarker in Breast Cancer Patients. Precision Medicine Communications, [S. l.], v. 3, n. 1, p. 11–26, 2023. DOI: 10.55627/pmc.003.01.0300. Disponível em: https://rootspress.org/journals/PMC/article/view/300. Acesso em: 2 apr. 2026.